Join experts from biopharma sponsors and research site staff in a discussion of approaches to maintaining trial quality when enrollment speed and volume are independent risk factors.  After the protocols are written, what tactics are effective in protecting patient safety and data integrity during fast enrollment?  Leveraging case studies from vaccine and COVID trials, the speakers will share their experiences and approaches with the goal of equipping the audience with key considerations for planning for rapid and high enrollment trials.